Terms of Use

By accessing or using this website, you agree to be bound by these Terms of Use and our Privacy Policy. If you do not agree, please do not use this site.

This website is operated by Byrock Technologies Limited to provide information about the PTP-102 veterinary clinical trial and to allow horse owners and veterinary professionals to express preliminary interest in study participation. The site relates to a trial conducted by Dr. Anthony Stachowski, DVM (Stachowski Alpacas, Mantua, Ohio) under FDA Center for Veterinary Medicine (CVM) oversight as an Investigational New Animal Drug (INAD) study.

PTP-102 is an investigational new animal drug (INAD) under FDA CVM review. It has not been approved as safe or effective for any indication. All use is investigational only.

Nothing on this website constitutes a representation, warranty, or claim that PTP-102 is safe, effective, curative, or beneficial for horses or any other animals. We make no claims regarding the investigational product.

The content of this website is provided for informational purposes only. It does not constitute veterinary or medical advice, diagnosis, or treatment. You should not delay seeking professional veterinary care, disregard your veterinarian's advice, or make treatment decisions based on information contained on this website.

If your horse is experiencing a veterinary emergency — including an acute laminitis episode — contact a licensed veterinarian immediately.

Participation in the PTP-102 clinical trial is entirely voluntary. Submitting the form on this website does not constitute enrollment in the study, nor does it create any obligation on your part. You are free to withdraw your interest at any time, for any reason, without consequence.

You will not be enrolled in the study without signing an informed consent form, and you may withdraw from the study at any time before or during participation.

To the fullest extent permitted by applicable law, Byrock Technologies Limited, its directors, employees, and agents shall not be liable for any direct, indirect, incidental, special, consequential, or exemplary loss or damage of any kind arising out of or in connection with:

• Your use of, or inability to use, this website
• Any information obtained from or through this website, whether accurate or not
• Any decision made, or action taken, based on content found on this website
• Your participation or non-participation in the clinical trial

We make no warranties, express or implied, regarding the accuracy, completeness, or fitness for purpose of any content on this website.

All content on this website — including text, graphics, logos, and design — is the property of Byrock Technologies Limited or its licensors and is protected by applicable copyright and intellectual property law. You may not reproduce, distribute, or create derivative works from any content on this site without our prior written consent.

This website may contain links to third-party websites (for example, regulatory authorities such as the FDA or Irish Data Protection Commission). These links are provided for convenience only. Byrock Technologies Limited is not responsible for the content, accuracy, or privacy practices of any third-party site.

These Terms of Use are governed by and construed in accordance with the laws of Ireland, without regard to its conflict-of-law provisions. Any disputes arising out of or in connection with these Terms shall be subject to the exclusive jurisdiction of the courts of Ireland.

We may update these Terms of Use from time to time. The “Last updated” date at the top of this page reflects the most recent revision. Continued use of this website following any changes constitutes your acceptance of the updated Terms.

Questions about these Terms should be directed to: